Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19

References (22)

1. 1 Clinical Characteristics of Coronavirus Disease 2019 in China [DOI]
2. 2 Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro [DOI]
3. 3 RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial [DOI]
4. 4 In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) [DOI]
5. 5 Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies [DOI]
6. 6 Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro [DOI]
7. 7 Chloroquine is a potent inhibitor of SARS coronavirus infection and spread [DOI]
8. 8 Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study [DOI]
9. 9 In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine [DOI]
10. 10 New insights into the antiviral effects of chloroquine [DOI]
11. 11 Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19 [DOI]
12. 12 Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France [DOI]
13. 13 Mechanism of action of hydroxychloroquine as an antirheumatic drug [DOI]
14. 14 Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model [DOI]
15. 15 Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection [DOI]
16. 16 Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis [DOI]
17. 17 Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19. [DOI]
18. 18 Optimizing Hydroxychloroquine Dosing for Patients With COVID‐19: An Integrative Modeling Approach for Effective Drug Repurposing [DOI]
19. 19 Azithromycin induces anti-viral effects in cultured bronchial epithelial cells from COPD patients [DOI]
20. 20 Emerging prophylaxis strategies against COVID-19 [DOI]
21. 21 Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial [DOI]
22. 22 Treatment Response to Hydroxychloroquine, Lopinavir–Ritonavir, and Antibiotics for Moderate COVID-19: A First Report on the Pharmacological Outcomes from South Korea [DOI]

Cited by 52

Showing 20 of 52 known citations — external sources report more than can currently be individually listed.

Related research

• Covid-2019:“A Microbiological Monster” — shares topic coverage
• COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
• Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): What Can Africa Learn from Ongoing Research in Epidemiology, Clinical Manifestations, Chemotherapy and Prevention? — shares topic coverage
• Early Treatment with Hydroxychloroquine Improves Clinical Outcomes and Reduces Hospital Admissions in COVID-19 Associated Pneumonia — shares topic coverage
• A Review on Intranasal Covid Vaccines for SARS-CoV-2 — shares topic coverage